Updated:
REGENEREX PHARMA, INC.
REGENEREX PHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001357878, and its reported industry...
Overview
REGENEREX PHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001357878, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-06-30, it reported net income of USD -2,527,041; total assets of USD 1,263,236 for the fiscal period ended 2025-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- REGENEREX PHARMA, INC.
- Former names in filing history
- PEPTIDE TECHNOLOGIES, INC. (2011-10-13 to 2021-12-22); Eternelle Skincare Products Inc. (2017-06-23 to 2018-02-08); CREENERGY Corp (2010-06-29 to 2011-10-06); ONLINE ORIGINALS, INC (2006-04-18 to 2010-07-19)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Las Vegas, NV, United States
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 0001357878
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2024USD | -$2.5M | $1.3M | $653,025 | -$1.6M | |
| FY2023USD | -$3.5M | $766,680 | $372 | -$457,548 | |
| FY2023USD | -$137,330 | $6,539 | $1,135 | -$76,164 | |
| FY2022USD | -$195,591 | $15,322 | $2,640 | -$69,922 |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2025 | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2025 | ||
| 8-K | CURRENT REPORT | ||
| 10-K | ANNUAL REPORT FOR THE FISCAL YEAR ENDED MARCH 31, 2025 |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research REGENEREX PHARMA, INC. in Altss
Track this company’s investors, transactions and relationships in Altss.